Trials / Completed
CompletedNCT03513523
Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
A Randomized, Double-Blind, Double-Dummy, Placebo-Controlled Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 111 (actual)
- Sponsor
- Elysium Health · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine if there is a relationship between daily consumption of NRPT, over a six-month (26-week) period, and changes in liver fat accumulation, compared to placebo and change from Baseline in healthy volunteers. In addition, an exploratory assessment of markers of inflammation and liver fat metabolism will be examined.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Group 1 NRPT | Two capsules of NRPT and two placebo will be taken once daily in the morning for 26 weeks. Each NRPT capsule will contain 125 mg NR and 25 mg PT. |
| DIETARY_SUPPLEMENT | Group 2 NRPT | Four capsules of NRPT will be taken once daily in the morning for 26 weeks. Each NRPT capsule will contain 125 mg NR and 25 mg PT. |
| OTHER | Group 3 Placebo | Four placebo capsules will be taken once daily in the morning for 26 weeks. |
Timeline
- Start date
- 2018-04-18
- Primary completion
- 2020-05-10
- Completion
- 2020-08-17
- First posted
- 2018-05-01
- Last updated
- 2020-10-26
Locations
9 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03513523. Inclusion in this directory is not an endorsement.